Edesa Biotech, Inc.
Current role
EDSA
Biotechnology · Healthcare
CEO, Board Member
2019-01-01–present
Pardeep Nijhawan
Board Member
Edesa Biotech, Inc. (EDSA)Equibles does not estimate personal net worth.
Get an email with a short summary when Edesa Biotech, Inc. publishes a filing, an earnings call transcript or a press release.
Get EDSA alertsAbout Pardeep Nijhawan
Pardeep Nijhawan is recorded as Board Member at Edesa Biotech, Inc. (EDSA) since January 1, 2019 and CEO at Edesa Biotech, Inc. (EDSA). The newest filing on record that lists Pardeep Nijhawan as CEO and Board Member at Edesa Biotech, Inc. (EDSA) is dated April 3, 2026. Edesa Biotech, Inc. reported in an 8-K filed May 29, 2026 that Pardeep Nijhawan was appointed member of the Company's board of directors, effective May 27, 2026. Edesa Biotech, Inc. reported in an 8-K filed May 28, 2025 that Pardeep Nijhawan was appointed Director, effective May 28, 2025. Edesa Biotech, Inc. reported in an 8-K filed May 30, 2024 that Pardeep Nijhawan was appointed Director, effective May 30, 2024. Equibles holds 4 filed executive changes naming Pardeep Nijhawan; each is listed under recent activity with its source filing. The proxy statement of Edesa Biotech, Inc. reports total compensation of $1,006,759 for Pardeep Nijhawan in fiscal 2025, including a base salary of $357,696. Disclosed compensation is on record for 4 fiscal years. Edesa Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edesa Biotech, Inc. includes Carlo Sistilli (Chairman and Board Member), Peter J. Weiler (CFO), Peter Weiler (CFO) and 7 others.
“the shareholders elected Joan Chypyha, David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli to serve as members of the Company's board of directors until the annual meeting of shareholders to be held in 2027 or until their successors are duly elected and qualified.”
“the shareholders elected Joan Chypyha, David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli to serve as members of the Company's board of directors until the annual meeting of shareholders to be held in 2026 or until their successors are duly elected and qualified.”
Affiliation history
-
Current
2019-01-01–present
Last confirmed April 3, 2026
-
Current
Start not stated–present
Last confirmed April 3, 2026
Company network
Leadership on record at Edesa Biotech, Inc.
- Carlo Sistilli Chairman, Board Member
- Peter J. Weiler CFO
- Peter Weiler CFO
- Stephen Lemieux CFO
- Carlo Sistilli, CPA, CMA Board Member
- Charles Olson Board Member
- Charles V. Olson Board Member
- David Liu Board Member
- Jennifer Chao Board Member
- Joan Chypyha Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Edesa Biotech, Inc. (EDSA) | Director, Chief Executive Officer and Corporate Secretary | $357,696 | $1,006,759 |
| 2024 | Edesa Biotech, Inc. (EDSA) | Director, Chief Executive Officer and Corporate Secretary ^^ | $357,696 | $464,728 |
| 2023 | Edesa Biotech, Inc. (EDSA) | Director, Chief Executive Officer and Corporate Secretary ^^ | $341,391 | $549,561 |
| 2019 | Edesa Biotech, Inc. (EDSA) | Director, Chief Executive Officer and Corporate Secretary | $105,461 | $130,032 |